Expression changes of hippocampal energy metabolism enzymes contribute to behavioural abnormalities during chronic morphine treatment

Cell Research

Volumn 17, Issue 8, 2007, Pages 689-700

  Chen, Xiao Lan ^a   Lu, Gang ^a   Gong, Ying Xia ^b   Zhao, Liang Cai ^c   Chen, Jie ^a   Chi, Zhi Qiang ^a   Yang, Yi Ming ^a   Chen, Zhong ^b   Li, Qing Lin ^c   Liu, Jing Gen ^a  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c ANHUI UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Dependence; Glucose; Hippocampus; Learning and memory; Morphine

Indexed keywords

DIHYDROLIPOAMIDE ACETYLTRANSFERASE; GLUCOSE; IRON SULFUR PROTEIN; ISOENZYME; LACTATE DEHYDROGENASE; LACTATE DEHYDROGENASE 2; MESSENGER RNA; MORPHINE; NARCOTIC ANALGESIC AGENT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; CARBOHYDRATE METABOLISM; DRUG EFFECT; ENERGY METABOLISM; GENE EXPRESSION; GENETICS; HIPPOCAMPUS; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MASS SPECTROMETRY; MAZE TEST; MEMORY; METABOLISM; MOTOR ACTIVITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ANALGESICS, OPIOID; ANIMALS; CARBOHYDRATE METABOLISM; DIHYDROLIPOYLLYSINE-RESIDUE ACETYLTRANSFERASE; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ENERGY METABOLISM; GENE EXPRESSION; GLUCOSE; HIPPOCAMPUS; INJECTIONS, INTRAPERITONEAL; IRON-SULFUR PROTEINS; ISOENZYMES; L-LACTATE DEHYDROGENASE; MALE; MASS SPECTROMETRY; MAZE LEARNING; MEMORY; MORPHINE; MOTOR ACTIVITY; NADH DEHYDROGENASE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SODIUM CHLORIDE;

MUS;

EID: 34547918341     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/cr.2007.63     Document Type: Article

References (54)

1. Nestler EJ. Under siege: the brain on opiates. Neuron 1996; 16:897-900.
2. Kest B, Palmese CA, Hopkins E, Adler M, Juni A, Mogil S. Naloxone-precipitated withdrawal jumping in 11 inbred mouse strains: evidence for common genetic mechanisms in acute and chronic morphine physical dependence. Neuroscience 2002; 115:463-469.
3. Mclemore GL, Kest B, Inturrisi CE. The effects of LY293558, an AMPA receptor antagonist, on acute and chronic morphine dependence. Brain Res 1997; 778:120-126.
4. Schulteis G, Heyser CH, Koob GF. Opiate withdrawal signs precipitated by naloxone following a single exposure to morphine: potentiation with a second morphine exposure. Psychopharmacology(Berl) 1997; 129:6-65.
5. Guerra D, Sole J, Tobena A. Neuropsychological performance in opiate addicts after rapid detoxification. Drug Alcohol Depend 1987; 20:261-270.
6. Stefani MR, Nicholson GM, Gold PE. ATP-sensitive potassium channel blockade enhances spontaneous alteration performance in the rat: a potential mechanism for glucose-mediated memory enhancement. Neuroscience 1999; 93:557-563.
7. Li Z, Wu CF, Pei G, Xu NJ. Reversal of morphine-induced memory impairment in mice by withdrawal in Morris water maze: possible involvement of cholinergic system. Pharmacol Biochem Behav 2001; 68:507-513.
8. Pu L, Bao GB, Xu NJ, Ma L, Pei G. Hippocampal long-term potentiation is reduced by chronic opiate treatment and can be restored by re-exposure to opiates. J Neurosci 2002; 22:1914-1921.
9. Nestler EJ. Common molecular and cellular substrates of addiction and memory. Neurobiol Learn Mem 2002; 78:637-647.
10. Everitt BJ, Robbins TW. Central cholinergic systems and cognition. Annu Rev Psychol 1997; 48:649-684.
11. Rezayof A, Zarrindast MR, Sahraei H, Haeri-Rohani A. Involvement of dopamine receptors of the dorsal hippocampus on the acquisition and expression of morphine-induced place preference in rats. J Psychopharmacol 2003; 17:415-423.
12. Rezayof A, Zatali H, Haeri-Rohani A, Zarrindast MR. Dorsal hippocampal muscarinic and nicotinic receptors are involved in mediating morphine reward. Behav Brain Res 2006; 166:281-290.
13. Zarrindast MR, Massoudi R, Sepehri H, Rezayof A. Involvement of GABA(B) receptors of the dorsal hippocampus on the acquisition and expression of morphine-induced place preference in rats. Physiol Behav 2006; 87:31-38.
14. Done C, Silverstone P, Sharp T. Effect of naloxone-precipitated morphine withdrawal on noradrenaline release in rat hippocampus in vivo. Eur J Pharmacol 1992; 215:333-336.
15. Fan GH, Wang LZ, Qiu HC, Ma L, Pei G. Inhibition of calcium/calmodulin- dependent protein kinase II in rat hippocampus attenuates morphine tolerance and dependence. Mol Pharmacol 1999; 56:39-45.
16. Lu L, Zeng S, Liu D, Geng X. Inhibition of the amygdala and hippocampal calcium/calmodulin-dependent protein kinase II attenuates the dependence and relapse to morphine differently in rats. Neurosci Lett 2000; 291:191-195.
17. Vorel SR, Liu X, Hayes RJ, Spector JA, Gardner EL. Relapse to cocaine-seeking after hippocampal theta burst stimulation. Science 2001; 292:1175-1178.
18. Kalant H. Problems in the search for mechanisms of tolerance. Alcohol Alcohol Suppl 1993; 2:1-8.
19. Dodge PW, Takemori AE. Effects of morphine, nalorphine and pentobarbital alone and combination on cerebral glycolytic substrates and cofactors of rats in vivo. Biochem Pharmacol 1972; 21:287-294.
20. Sherman AD, Mitchell CL. Effects of morphine and pain on brain intermediary metabolism. Neuropharmacology 1972; 11:871-877.
21. Sood PP, Mohanakumar KP. Changes in succinic dehydrogenase activity in the central nervous system of mice during morphine dependence development, withdrawal and naloxone treatment. Clin Physiol Biochem 1985; 3:193-198.
22. Stone WS, Rudd RJ, Gold PE. Glucose and physostigmine effects on morphine- and amphetamine-induced increase in locomotor activity in mice. Behav Neural Biol 1990; 54:146-155.
23. Ragozzino ME, Gold PE. Glucose injections into the medial septum reverse the effects of intraseptal morphine infusions on hippocampal acetylcholine output and memory. Neuroscience 1995; 68:981-988.
24. Talley CP, Arankowsky-Sandoval G, McCarty R, Gold PE. Attenuation of morphine-induced behavioral changes in rodents by D- and L-glucose. Neurobiol Learn Mem 1999; 71:62-79.
25. Jafari MR, Zarrindast MR, Djahanguiri B. Effects of different doses of glucose and insulin on morphine state-dependent memory of passive avoidance in mice. Psychopharmacology 2004; 175:457-462.
26. Shook JE, Kachur JF, Brase DA, Dewey WL. Morphine dependence and diabetes. II. Alteration of normorphine potency in the guinea-pig ileum and mouse vas deferens and of ileal morphine dependence by changes in glucose concentration. J Pharmacol Exp Ther 1986; 237:848-852.
27. Akunne HC, Soliman KF. Hyperglycemic suppression of morphine withdrawal signs in the rat. Psychopharmacol 1988; 96:1-6.
28. Kamei J, Ohsawa M, Saitoh A, et al. Modification of mu-opioid agonist-induced locomotor activity and development of morphine dependence by diabetes. J Pharmacol Exp Ther 1995; 274:700-706.
29. McClung CA, Nestler EJ, Zachariou V. Regulation of gene expression by chronic morphine and morphine withdrawal in the locus ceruleus and ventral tegmental area. J Neurosci 2005; 25:6005-6015.
30. Guo GW, He Y, Jin WQ, Zou Y, Zhu YC, Chi ZQ. Comparison of physical dependence of ohmefentanyl stereoisomers in mice. Life Sci 2000; 67:113-120.
31. Paxinos G, Franklin KBJ. The mouse brain in stereotaxic coordinates. 2nd Edition. San Diego: :Academic Press, 2004.
32. Ragozzino ME, Parker ME, Gold PE. Spontaneous alteration and inhibitory avoidance impairments with morphine injections into the medical septum. Attenuation by glucose administration. Brain Res 1992; 597:241-249.
33. Langen H, Roder D, Juranville JF, Fountoulakis M. Effect of protein application mode and acrylamide concentration on the resolution of protein spots separated by two-dimensional gel electrophoresis. Electrophoresis 1997; 18:2085-2090.
34. Yan JX, Wait R, Berkelman T, et al. A modified silver staining protocol for visualization of proteins compatible with matrix-assisted laser desorption/ionization and electrospray ionizationmass spectrometry. Electrophoresis 2000; 21:3666-3672.
35. Piubelli C, Galvani M, Hamdan M, Domenici E, Righetti PG. Proteome analysis of rat polymorphonuclear leukocytes: a two-dimensional electrophoresis/mass spectrometry approach. Electrophoresis 2002; 23:298-310.
36. Perkins DN, Pappin DJ, Creasy DM, Cottrell JS. Probabilitybased protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 1999; 20:3551-3567.
37. Messier C. Glucose improvement of memory: a review. Eur J Pharmacol 2004; 490:33-57.
38. 8 Sadava D, Alonso D, Hong H, Pettit-Barrett DP. Effects of methadone addiction on glucose metabolism in rats. Gen Pharmacol 1997; 28:27-29.
39. Gomaa AA, Moustafa A, Farghali AA. Adenosine triphosphate blocks opiate withdrawal symptoms in rats and mice. Pharmacol Toxicol 1989; 64:111-115.
40. Kaplan GB, Coyle TS. Adenosine kinase inhibitors attenuate opiate withdrawal via adenosine receptor activation. Eur J Pharmacol 1998; 362:1-8.
41. Morris RG, Anderson E, Lynch GS. Selective impairment of learning and blockade of long-term potentiation by an AT-methyl-D-aspartate receptor antagonist, AP5. Nature 1986; 319:774-776.
42. Ragozzino ME, Gold PE. Glucose injections into the medial septum reverse the effects of intraseptal morphine infusions on hippocampal acetylcholine output and memory. Neuroscience 1995; 68:981-988.
43. Sharif SI, eL-Kadi AO. The role of cholinergic systems in the expression of morphine withdrawal. Neurosci Res 1996; 25:155-160.
44. Buccafusco JJ, Zhang LC, Shuster LC, Jonnala RR, Gattu M. Prevention of precipitated withdrawal symptoms by activating central cholinergic systems during a dependence-producing schedule of morphine in rats. Brain Res 2000; 852:76-83.
45. Walker DL, McGlynn T, Grey C, Ragozzino M, Gold PE. Naloxone modulates the behavioral effects of cholinergic agonists and antagonists. Psychopharmacology 1991; 105:57-62.
46. Ragozzino ME, Wenk GL, Gold PE. Glucose attenuates a morphine-induced decrease in hippocampal acetylcholine output: an in vivo microdialysis study in rats. Brain Res 1994; 655:77-82.
47. Ragozzino ME, Unick KE, Gold PE. Hippocampal acetylcholine release during memory testing in rats: augmentation by glucose. Proc Natl Acad Sci USA 1996; 93:4693-4698.
48. Ragozzino ME, Pal SN, Unick K, Stefani MR, Gold PE. Modulation of hippocampal acetylcholine release and spontaneous alternation scores by intrahippocampal glucose injections. J Neurosci 1998; 18:1595-1601.
49. Trujillo KA, Akil H. Excitatory amino acids and drugs of abuse: a role for N-methyl-D-aspartate receptors in drug tolerance, sensitization and physical dependence. Drug Alcohol Depend 1995; 38:139-154.
50. Cousins MS, Roberts DC, de Wit H. GABA(B) receptor agonists for the treatment of drug addiction: a review of recent findings. Drug Alcohol Depend 2002; 65:209-220.
51. Cunha RA, Ribeiro JA. Purinergic modulation of [(3)H]GABA release from rat hippocampal nerve terminals. Neuropharmacology 2000; 39:1156-1167.
52. Mendoza-Fernandez V, Andrew RD, Barajas-Lopez C. ATP inhibits glutamate synaptic release by acting at P2Y receptors in pyramidal neurons of hippocampal slices. J Pharmacol Exp Ther 2000; 293:172-179.
53. Masino SA, Diao L, Ules P, et al. Modulation of hippocampal glutamatergic transmission by ATP is dependent on adenosine Al receptors. J Pharmacol Exp Ther 2002; 303:356-363.
54. Salem A, Hope W. Effect of adenosine receptor agonists and antagonists on the expression of opiate withdrawal in rats. Pharmacol Biochem Behav 1997; 57:671-679.